← Leaderboards
Stefan H Bossmann
University Of Kansas Lawrence
$2,979,999
Attributed
$3,827,180
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,827,180 · 5
By mechanism
S10$2,000,000 · 1
R01$1,694,363 · 1
P20$132,817 · 3
Top collaborators
- David Akhavan3 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCellsDesignUnited States National Institutes Of HealthKansasComplexInstitutionFundingResourcesUniversitiesResearch PersonnelTechnologyBody PartAdoptive Cell TransfersCell PhysiologyBiochemicalCell KillingBinding (Molecular Function)AffectBathingCancer TherapyAdverse EffectsCancer SiteCancerous
Grant awards (7)
Design of a Novel Nanocarrier Technology to Drug-Load CAR T cells$574,360
R01 · FY2025 · CA
Zero Cryogen Boiloff Technology Magnet: A Regional Animal MRI Resource$2,000,000
S10 · FY2024 · OD · contact PI
Design of a Novel Nanocarrier Technology to Drug-Load CAR T cells$545,643
R01 · FY2024 · CA
Design of a Novel Nanocarrier Technology to Drug-Load CAR T cells$574,360
R01 · FY2023 · CA
TARGETING CANCER WITH PROTEIN-NANOPARTICLE COMPLEXES$40,126
P20 · FY2009 · RR · contact PI
TARGETING CANCER WITH PROTEIN-NANOPARTICLE COMPLEXES$71,458
P20 · FY2008 · RR · contact PI
TARGETING CANCER WITH PROTEIN-NANOPARTICLE COMPLEXES$21,233
P20 · FY2007 · RR · contact PI